| Literature DB >> 30787853 |
Yassir Zajjari1, Taoufiq Aatif1, Kawtar Hassani1, Sanaa Benbria1, Driss El Kabbaj1.
Abstract
BACKGROUND: The diagnosis of diabetic nephropathy is based on the course of clinical manifestations and renal biopsy. Renal biopsy is usually performed in patients with atypical presentations.Entities:
Keywords: Diabetic nephropathy; Morocco; nondiabetic renal disease; pathological classification; renal biopsy; type 2 diabetes
Year: 2018 PMID: 30787853 PMCID: PMC6381850 DOI: 10.4103/sjmms.sjmms_76_18
Source DB: PubMed Journal: Saudi J Med Med Sci ISSN: 2321-4856
Demographic data
| Variables | Group A ( | Group B ( | Group C ( | |
|---|---|---|---|---|
| Age (years ± SD) | 57.16 ± 7.87 | 57.35 ± 6.66 | 62.5 ± 3.5 | 0.61 |
| Male, | 19 (79.16) | 10 (71.4) | 1 (50) | 0.61 |
Group A – Patients with isolated diabetic nephropathy; Group B –Patients with isolated nondiabetic renal diseases; Group C – Nondiabetic renal disease superimposed on underlying diabetic nephropathy; SD – Standard deviation
Comparison of various parameters between different types of nephropathies
| Parameters | Group A ( | Group B ( | Group C ( | |
|---|---|---|---|---|
| Diabetes duration (years ± SD) | 11.62 ± 8.18 | 4.42 ± 3.15 | 5.50 ± 0.70 | 0.009 |
| Diabetic retinopathy, | 18 (75) | 2 (14.2) | 0 | 0.001 |
| Proteinuria (g/day ± SD) | 4.88 ± 2.62 | 5.65 ± 3.33 | 3.50 ± 0.70 | 0.53 |
| Hematuria, | 10 (41.66) | 12 (85.71) | 1 (50) | 0.02 |
| Hypertension, | 18 (75) | 7 (50) | 1 (50) | 0.26 |
| Dyslipidemia, | 15 (62.5) | 9 (64.28) | 0 | 0.20 |
| eGFR (±SD) (ml/min/1.73 m2) | 28.38 ± 18.6 | 49.85 ± 32.84 | 28 ± 16.97 | 0.04 |
| Mean HbA1c (percentage ± SD) | 7.79 ± 1.98 | 7.97 ± 1.32 | 7 ± 0 | 0.76 |
Group A – Patients with isolated diabetic nephropathy; Group B – Patients with isolated nondiabetic renal diseases; Group C – Patients with nondiabetic renal disease superimposed on underlying diabetic nephropathy; SD – Standard deviation; eGFR – Estimated glomerular filtration rate; HbA1c – Glycated hemoglobin
Histological diagnosis in patients with nondiabetic renal diseases
| Histology | Group B ( | Group C ( |
|---|---|---|
| Henoch-Schönlein purpura | 2 (12.5) | 1 (6.3) |
| Membranous nephropathy | 3 (18.8) | - |
| Myeloma cast nephropathy | 1 (6.3) | 1 (6.3) |
| Postinfectious glomerulonephritis | 2 (12.5) | 0 |
| Lupus nephritis | 2 (12.5) | 0 |
| Amyloidosis AA | 1 (6.3) | 0 |
| IgA nephropathy | 1 (6.3) | 0 |
| Minimal change disease | 1 (6.3) | 0 |
| Focal segmental glomerulosclerosis | 1 (6.3) | 0 |
Group B – Patients with isolated nondiabetic renal diseases; Group C – Patients with nondiabetic renal disease superimposed on underlying diabetic nephropathy
Clinical and biochemical parameters across different classes of diabetic nephropathy
| Parameter | Class IIA ( | Class IIB ( | Class III ( | Class IV ( | |
|---|---|---|---|---|---|
| Mean age of patients (years ± SD) | 57 ± 6.68 | 58.5 ± 3.53 | 56.45 ± 6.72 | 59 ± 10.34 | 0.91 |
| Mean duration of diabetes (years ± SD) | 4.75 ± 1.25 | 3.5 ± 2.12 | 11.9 ± 4.63 | 14.77 ± 11.07 | 0.08 |
| Hypertension, | 2 (50) | 1 (50) | 8 (72.72) | 8 (88.88) | 0.42 |
| Hematuria, | 1 (25) | 1 (50) | 6 (54.54) | 3 (33.33) | 0.68 |
| Nephrotic syndrome, | 1 (25) | 2 (100) | 10 (90.90) | 7 (77.77) | 0.04 |
| Mean proteinuria levels (g/day ± SD) | 2.75 ± 0.95 | 4.50 ± 2.12 | 4.68 ± 1.61 | 5.86 ± 3.57 | 0.24 |
| Mean eGFR (ml/min/1.73 m2± SD) | 35 ± 12.93 | 55.55 ± 7.77 | 35.63 ± 15.22 | 10.46 ± 5.60 | <0.001 |
| Mean HbA1c (percentage ± SD) | 7.25 ± 0.50 | 6.50 ± 0.70 | 8.23 ± 2.67 | 7.60 ± 1.23 | 0.62 |
| Diabetic retinopathy, | 0 | 2 (100) | 8 (72.72) | 8 (88.88) | 0.009 |
SD – Standard deviation; eGFR – Estimated glomerular filtration rate; HbA1c – Glycated hemoglobin
Pathological details across different classes of diabetic nephropathy
| Parameter | Class IIA ( | Class IIB ( | Class III ( | Class IV ( | |
|---|---|---|---|---|---|
| Mean number of glomeruli ± SD | 10 ± 0 | 12 ± 0 | 18.90 ± 14.45 | 15.66 ± 3.77 | 0.45 |
| Percentage of glomerulosclerosis ± SD | 20 ± 8.16 | 15 ± 7.07 | 34.72 ± 15.45 | 48.88 ± 20.88 | 0.01 |
| Mean IFTA score ± SD | 0.75 ± 0.5 | 1 ± 0 | 1.63 ± 0.67 | 2.55 ± 0.52 | <0.001 |
| Mean ITA score ± SD | 0 | 0 | 0.54 ± 0.52 | 1 ± 0 | <0.001 |
| Mean arteriolar hyalinosis score ± SD | 0.75 ± 0.5 | 0.5 ± 0.7 | 0.72 ± 0.64 | 0.88 ± 0.6 | 0.85 |
| Mean arteriosclerosis score ± SD | 0.5 ± 0.57 | 0 | 1 ± 0.44 | 1.44 ± 0.52 | 0.002 |
IFTA – Interstitial fibrosis and tubular atrophy; ITA – Interstitial inflammation; SD – Standard deviation